Search

everythinglearnresearchcommunity

for

Search:↓

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Tinea capitis, a scalp fungal infection in children, is best treated with newer antifungal agents for shorter periods.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

UV light can help stimulate the growth of new pigment cells from hair follicles in people with vitiligo.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Adrenal disorders can cause lasting brain and behavior issues in children.

Certain hormone treatments can improve acne and related conditions in women.

Itchy scalp is common, linked to various conditions, and hard to treat effectively.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Scalp seborrheic dermatitis is a common skin condition linked to oil production and bacteria, with specific diagnostic features and treatments like antifungals and corticosteroids.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

Bee venom, fig, and geranium oil can effectively treat skin conditions and are safer alternatives to some conventional drugs.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.